| Q37395241 | A combined vascular surgical and clinical genetics approach to diffuse aneurysmal disease |
| Q44061893 | A new COL3A1 mutation in Ehlers-Danlos syndrome type IV. |
| Q89520494 | A review of thoracic aortic aneurysm disease |
| Q50141060 | Acute aortic syndromes: diagnosis and management, an update |
| Q37896682 | Advances in stroke care and research in 2010. |
| Q35790300 | Allele-specific siRNA knockdown as a personalized treatment strategy for vascular Ehlers-Danlos syndrome in human fibroblasts |
| Q38006747 | Are we ignoring the dilated thoracic aorta? |
| Q92150156 | Atypical COL3A1 variants (glutamic acid to lysine) cause vascular Ehlers-Danlos syndrome with a consistent phenotype of tissue fragility and skin hyperextensibility |
| Q57197763 | Authors’ Response |
| Q64045766 | Bowel perforation in type IV vascular Ehlers-Danlos syndrome. A systematic review |
| Q42913578 | Celiprolol therapy for vascular Ehlers-Danlos syndrome |
| Q41322349 | Celiprolol: A Unique Selective Adrenoceptor Modulator |
| Q36296835 | Chronic treatment with a broad-spectrum metalloproteinase inhibitor, doxycycline, prevents the development of spontaneous aortic lesions in a mouse model of vascular Ehlers-Danlos syndrome. |
| Q36497322 | Clinical utility gene card for: Ehlers-Danlos syndrome types I-VII and variants - update 2012 |
| Q30301251 | Conditions presenting with symptoms of peripheral arterial disease |
| Q85413166 | Connective tissue disorders and cervical artery dissections: inherited or acquired connections? |
| Q41118476 | Consensus Document of the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Pediatric Cardiology (SICP), and Italian Society of Gynaecologists and Obstetrics (SIGO): pregnancy and congenital heart diseases |
| Q85427912 | Coronary artery disease. Are β-blockers truly helpful in patients with CAD? |
| Q24631384 | Doxycycline ameliorates the susceptibility to aortic lesions in a mouse model for the vascular type of Ehlers-Danlos syndrome |
| Q26853455 | Educational paper. Connective tissue disorders with vascular involvement: from gene to therapy |
| Q51445001 | Ehlers-Danlos Syndrome Type IV: A Case Report. |
| Q87515900 | Ehlers-Danlos syndrome - a commonly misunderstood group of conditions |
| Q46556412 | Ehlers-Danlos syndrome, vascular type: a novel missense mutation in the COL3A1 gene |
| Q38226265 | Ehlers-Danlos syndrome: how to diagnose and when to perform genetic tests |
| Q53110063 | Embolization of life-threatening arterial rupture in patients with vascular Ehlers-Danlos syndrome. |
| Q54037915 | Familial Ehlers-Danlos syndrome with lethal arterial events caused by a mutation in COL5A1. |
| Q40074360 | Genes in Thoracic Aortic Aneurysms and Dissections - Do they Matter?: Translation and Integration of Research and Modern Genetic Techniques into Daily Clinical Practice |
| Q42226301 | Genes in thoracic aortic aneurysms/dissections - do they matter? |
| Q36526049 | Genetic dissection of marfan syndrome and related connective tissue disorders: an update 2012. |
| Q38601760 | Genetics of hereditary large vessel diseases |
| Q26828019 | Genetics of thoracic aortic aneurysm: at the crossroad of transforming growth factor-β signaling and vascular smooth muscle cell contractility |
| Q53413697 | How to prevent the next Marathon Pharmaceuticals. |
| Q94552064 | Inherited Thoracic Aortic Disease: New Insights and Translational Targets |
| Q38497709 | Managing aortic aneurysms and dissections during pregnancy |
| Q35402977 | Molecular diagnosis in vascular Ehlers-Danlos syndrome predicts pattern of arterial involvement and outcomes |
| Q28088448 | Neurological manifestations of Ehlers-Danlos syndrome(s): A review |
| Q30393291 | New Insights Into Aortic Diseases: A Report From the Third International Meeting on Aortic Diseases (IMAD3) |
| Q37929160 | Pharmacological modulation of arterial stiffness |
| Q47304122 | Pharmacology and drug development in rare diseases: the attractiveness and expertise of the French medical pharmacology. |
| Q82872383 | Pharmacotherapy: Vascular Ehlers-Danlos syndrome |
| Q36980892 | Postpartum spontaneous coronary, vertebral, and mesenteric artery dissections: a case report |
| Q88637134 | Preconception Counseling for Patients With Thoracic Aortic Aneurysms |
| Q40834076 | Recurrent Abdominal Arterial Aneurysm Rupture |
| Q52746675 | Six uneventful pregnancy outcomes in an extended vascular Ehlers-Danlos syndrome family. |
| Q41615271 | Spontaneous Dissection of the Renal Artery in Vascular Ehlers-Danlos Syndrome |
| Q52991265 | Spontaneous Splenic Rupture in Vascular Ehlers-Danlos Syndrome. |
| Q33724686 | Spontaneous colon perforations associated with a vascular type of ehlers-danlos syndrome |
| Q37986887 | The Ehlers-Danlos syndrome, a disorder with many faces |
| Q98176931 | The Ehlers-Danlos syndromes |
| Q95619226 | The authors reply |
| Q38171408 | The collagenopathies: review of clinical phenotypes and molecular correlations |
| Q39402194 | The spectrum of spontaneous coronary artery dissection: illustrated review of the literature |
| Q48217824 | Transcriptome analysis of skin fibroblasts with dominant negative COL3A1 mutations provides molecular insights into the etiopathology of vascular Ehlers-Danlos syndrome. |
| Q65950306 | Type III collagen (COL3A1): Gene and protein structure, tissue distribution, and associated diseases. |
| Q84049839 | Ultrastructural scoring of skin biopsies for diagnosis of vascular Ehlers-Danlos syndrome |
| Q37981654 | Varying presentations in patients with symptomatic type IV vascular Ehlers-Danlos syndrome |
| Q88489621 | Vascular Ehlers-Danlos Syndrome Presenting as a Pulsatile Neck Mass: a Case Report and Review of Literature |
| Q36695229 | Vascular Ehlers-Danlos Syndrome in siblings with biallelic COL3A1 sequence variants and marked clinical variability in the extended family |
| Q92482862 | Vascular Ehlers-Danlos Syndrome with a Novel Missense Mutation in COL3A1: A Man in His 50s with Aortic Dissection after Interventional Treatment for Hemothorax as the First Manifestation |
| Q42124683 | Vascular Ehlers-Danlos syndrome without the characteristic facial features: a case report |
| Q43150240 | Vascular Ehlers-Danlos syndrome: exploring the role of inflammation in arterial disease |
| Q47734987 | Vascular Smooth Muscle Cells and Arterial Stiffening: Relevance in Development, Aging, and Disease |
| Q47859621 | Vascular phenotypes in nonvascular subtypes of the Ehlers-Danlos syndrome: a systematic review |
| Q37148384 | Vascular type Ehlers-Danlos syndrome is associated with platelet dysfunction and low vitamin D serum concentration |
| Q36597166 | Vascular-type Ehlers-Danlos syndrome caused by a hitherto unknown genetic mutation: a case report |
| Q53089273 | [Rare syndromes in intensive care medicine : Presentation of two cases]. |
| Q37928128 | β-Adrenergic blockers |